Multiple Myeloma Therapeutics: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Millennium Pharmaceuticals, Seattle Genetics, and Ziopharm Oncology, Inc. Market data and analytics are derived from primary and secondary ...
October 2011
595 pages
Cancer Therapies: Market Research Report
US$ 4,500.00
... report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. ... 2017. A six-year historic analysis is also provided for these markets. The report profiles 152 companies including many key and ...
October 2011
897 pages
Gastrointestinal (GI) Endoscopy Devices: Market Research Report
US$ 4,500.00
This report analyzes the US market for Gastrointestinal (GI) Endoscopy Devices in US$ Million by the following Product Segments: GI Videoscopes (Video Colonoscopes, Video Gastroscopes, Video Duodenoscopes, Video Ultrasound Endoscopes, & Others (Includes Video Sigmoidoscope & Video Enteroscope)), Endoscopic ...
October 2011
284 pages
Cardiac Rhythm Management (CRM) Devices: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Cardiac Rhythm Management (CRM) Devices in US$ Million by the following Product Segments: Implantable Cardioverter Defibrillators (ICD), Pacemakers, External Defibrillators, and EP Catheterization, Mapping, and Ablation (CMA) devices. The report provides ...
October 2011
375 pages
Membrane Bioreactors: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Membrane Bioreactors in US$ Million by the following End-Use Segments: Municipal, and Industrial. The ... Corporation, Siemens Water Technologies, Toray Industries, Inc., and Veolia Environnement. Market data and analytics are derived from primary and secondary ...
October 2011
312 pages
Wound Care Products: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Wound Care Products in US$ Million. The major Product Segments analyzed are Traditional {Wound Management Products ( ... through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 200 companies including many key and niche ...
October 2011
1027 pages
Coronary Stents: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Coronary Stents in US$ Million and Thousand Units by the following Product Segments: Bare Metal ... Corporation, Medtronic, Inc., Medtronic Cardiovascular, Inc., OrbusNeich, and Terumo Europe N.V. Market data and analytics are derived from primary and secondary ...
October 2011
396 pages
Ambulatory and Bathroom Aids: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Ambulatory and Bathroom Aids in US$ Million and Thousand Units by the following Product Segments: ... Ltd., Rebotec Rehabilitationsmittel GmbH, Sunrise Medical, and Thomas Fetterman, Inc. Market data and analytics are derived from primary and secondary research. ...
October 2011
654 pages
Blood Glucose Meters And Strips: Market Research Report
US$ 4,500.00
... for Blood Glucose Meters and Strips in US$ Million by the following Product Segments: Blood Glucose Strips, and Blood Glucose Meters. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. ...
October 2011
446 pages
CIPLA, Para IV Upside To Continue: Its Lexapro After Zyprexa
US$ 350.00
... of $1b) under 180-day exclusivity starting 14 March 2012. Cipla remained an active partner to Ivax (now Teva) by developing ... -day exclusivity. Thus Cipla too will share the upsides from the exclusivity. We expect Cipla to gain $50m ... will start accruing immediately after the upside from Zyprexa API supply to Teva ...
October 2011
3 pages
Assessment of the Asian Medical Tourism Industry
US$ 800.00
... the developed countries. Apart from the US and Europe, the demand for private healthcare in Asia constitutes of patients from Africa and the Middle East, where the healthcare infrastructure is still under-developed. Why should the report be purchased? Our report ‘Assessment of the Asian Medical ...
October 2011
25 pages
Global Magnetic Resonance Imaging (MRI) Market: Advanced Technologies and Global Forecast (2011 - 2016)
US$ 5,650.00
... the largest market in MRI market by technology. MR angiography is a technique used for imaging of blood vessels and internal organs through magnetic resonance. The technique’s general ... ) and Hitachi (Japan). Scope of the report Global MRI Market research report evaluates the global market of Magnetic Resonance Imaging by architecture, by field strength, by technology market, by application ...
October 2011
MicroRNA Market Trends 2011
US$ 1,655.00
... from the bottom-up. This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of ... they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business ...
September 2011
139 pages
DAIICHI SANKYO - Edoxaban Gets Edge as Key Japanese Factor-Xa Inhibitors Fall!
US$ 140.00
Recent failures of Edoxaban’s key competitor factor-Xa inhibitors from Japan - YM 150 (Astellas) and TAK-442 (Takeda), the closest candidate in Japan now is Xarelto ... years away from hitting the market. Edoxaban is the first and only approved factor-Xa inhibitor in Japan for prevention of VTE, though Japanese ...
September 2011
4 pages
ROCHE, GLAXOSMITHKLINE - Exciting Data on TDM1 - Will Keep Competition at Bay
US$ 140.00
... months compared to Herceptin + docetaxel (14.2 m vs. 9.2 m- Table 1). The safety data as well, is very convincing as T-DM1 cut Grade 3 or more adverse effects ... 50% (46.4% vs. 89.4%). With T-DM1 and pertuzumab arrows in its quiver, Roche is well poised to sustain its breast cancer franchise beyond Herceptin ...
September 2011
4 pages
China Blood Products Industry Report, 2010-2011
US$ 2,000.00
Recent years have seen fast-growing development of blood product industry in China, with the enterprises concerned numbering 33 which can produce 10-odd blood products including human albumin, human i...
September 2011
85 pages
The UK Vitamin and Dietary Supplements Demand and Forecast
US$ 630.00
Executive summary The UK is one of the developed countries of Western Europe and has a well-formed nutrients & supplements market in the world. The industry has been registering growth primarily...
September 2011
36 pages
Observing Patients Online: the changing face of research
US$ 595.00
For years, patients have shouted to be heard. But as online patient communities, chat rooms and forums have gained popularity—and political clout—their voices are resonating.
Now being used t...
September 2011
47 pages
The 2011 Global Animal Health Market Dynamics and Trends
US$ 1,400.00
The report provides a strategic overview of the worldwide animal health market, including: Five-year forecasts for: Major market segments. Key ... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such ...
September 2011
12 pages
The 2011 Leading Animal Health Companies Strategic Directions
US$ 1,560.00
The companies analyzed in this report include Bayer, Boehringer Ingelhein, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol and Virbac. For each company, the report provides: Specific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and ...
September 2011
30 pages
The 2011 Leading Animal Health Companies Collaborative Arrangements
US$ 1,200.00
Each company analysis provides: Major joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, ...
September 2011
65 pages
The 2011 Leading Animal Health Companies Technological Know-How
US$ 1,520.00
Each company analysis provides: Internally developed and acquired animal health technologies, processes and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, Pfizer, Schering- ...
September 2011
30 pages
The 2011 Leading Animal Health Companies Product Portfolio Analyses
US$ 1,200.00
The companies analyzed in this report include Bayer, Boehringer Ingelheim, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol, and Virbac. For each company, the report provides: Extensive review of major product lines. Recently introduced products and line extensions. Contains 100 pages
September 2011
100 pages
The 2011 Leading Animal Health Companies Marketing Tactics
US$ 1,560.00
The companies analyzed in this report include Bayer, Boehringer Ingelheim, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, Vetoquinol, and Virbac. For each company, the report provides: Sales force size in the U.S. and other markets. Promotional tactics. Distribution approaches. Product service and ...
September 2011
38 pages
Emerging Infectious Disease Testing Technologies and Market Applications
US$ 760.00
This report provides a detailed analysis of the current and emerging technologies, and their potential applications for the infectious disease testing market, including DNA probes, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several ...
September 2011
61 pages
The 2011 Global Orthopedics Market Dynamics and Trends
US$ 1,480.00
... categories. In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globalization, environmental regulations, etc. The analysis of major ...
September 2011
53 pages
The 2011 Global Pharmaceutical Market Dynamics and Trends
US$ 1,480.00
A 25-page worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for key geographic regions: North America, Europe, Japan, Latin America. Sales ...
September 2011
25 pages
Ear Care in Turkey
US$ 990.00
... OTC products to be sold in supermarkets and drugstore chains. Euromonitor International's Ear Care in Turkey report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Ear Care market; Pinpoint growth sectors and identify factors driving change ...
September 2011
22 pages
Medicated Skin Care in Tunisia
US$ 990.00
... as anti-bacterial, lightening and sun protection products. Euromonitor International's Medicated Skin Care in Tunisia report offers a comprehensive guide to the size and shape of the ... and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy ...
September 2011
19 pages
Emerging Markets: Chinese and Indian Dental Prosthetics and CAD/CAM Devices 2011
US$ 7,495.00
In 2010, the total Chinese and Indian markets for Dental Prosthetics and CAD/CAM were valued at nearly $666 million, a 7.5% increase over ... System, Standalone Scanner, Chairside System, Within the vascular access device market, companies such as Sirona, 3Shape, DentSply Friadent and AmannGirrbach lead the ...
September 2011
240 pages
U.S. Market for Emergency Room Equipment 2011
US$ 7,495.00
... equipment was valued at over $960 million. The U.S. market for emergency room equipment includes: Patient monitoring, Imaging, Hitech, Cardiac, Vascular ... , Eithicon, GE Healthcare, Philips Healthcare and Zoll Medical lead the market, among many others. This report provides a comprehensive and detailed ...
September 2011
116 pages
U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing)
US$ 7,495.00
... Testing Urinalysis Testing Blood Glucose Testing In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food ... , companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides ...
September 2011
322 pages
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
European Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ...
September 2011
1353 pages
North American Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the North American pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Cardiovascular Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... , demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Global CNS Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan, ... , capabilities, goals and strategies of the leading players in the global CNS drug market. To help current suppliers realistically assess their financial ...
September 2011
1353 pages
